基于转基因斑马鱼抗血管生成中药活性成分筛选及其作用机制研究的中期报告.docxVIP

基于转基因斑马鱼抗血管生成中药活性成分筛选及其作用机制研究的中期报告 摘要： 本研究旨在通过使用转基因斑马鱼模型来筛选出具有抗血管生成活性的中药活性成分，并研究其作用机制。本研究分为三个阶段：首先，建立了一个转基因斑马鱼模型，该模型能够体现血管生成的生理和病理过程；其次，筛选了一批具有抗血管生成活性的中药活性成分，并进行了初步的药理评价；最后，通过基因表达谱和免疫荧光染色技术分析了这些活性成分对血管生成途径的调节作用。 实验结果表明，我们成功建立了转基因斑马鱼模型，该模型可用于评价具有抗血管生成活性的物质。我们筛选出了十多种表现出抑制血管生成能力的中药活性成分，其中一些成分已经被广泛应用于治疗心脑血管疾病，如当归、黄芪等。进一步的研究表明，这些活性成分通过抑制血管生成途径中的一些关键基因表达来发挥抗血管生成的作用。 综上所述，我们的研究为寻找具有抗血管生成活性的中药活性成分提供了新思路和新方法。本研究的成果不仅对中药研究具有重要意义，也有望为心脑血管疾病的治疗提供新的药物研发思路。 关键词：转基因斑马鱼模型；抗血管生成；中药活性成分；作用机制 Abstract: The aim of this study is to screen out active ingredients of traditional Chinese medicine (TCM) with anti-angiogenesis activity and investigate their mechanisms of action using a zebrafish model. The study was divided into three stages: Firstly, a zebrafish model was established to reflect the physiological and pathological process of angiogenesis. Secondly, a batch of active ingredients with anti-angiogenic activity were screened and their pharmacological evaluations were conducted. Lastly, the regulatory effects of these active components on angiogenesis pathway were analyzed by gene expression profiling and immunofluorescence staining. Results showed that the zebrafish model was successfully established and it can be used to evaluate substances with anti-angiogenic activity. More than 10 traditional Chinese medicine active components with inhibitory ability on angiogenesis were screened, among which some have been widely used to treat cardiovascular and cerebrovascular diseases, such as Angelica sinensis, Astragalus membranaceus and so on. Further studies showed that these active components exert anti-angiogenic effects by inhibiting the expression of some critical genes involved in angiogenesis pathway. In conclusion, our study provides new ideas and methods for exploring active ingredients of TCM with anti-angiogenic activity. Results of this study have important implications for TCM research and provide new drug development thoughts for the treatment of cardiovascular and cerebrov